Trial Profile
A trial of liposomal GAP 107B8 for the treatment of ovarian cancer.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 17 Feb 2014
Price :
$35
*
At a glance
- Drugs GAP 107B8 (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- Sponsors PharmaGap
- 17 Feb 2014 Status changed from planning to discontinued.
- 22 Nov 2011 New trial record